BOTJ vs GSK · P/E 10, rev $2.1M vs P/E 13, $103.31B cap
Bank of the James Financial Group (BOTJ) versus GlaxoSmithKline PLC ADR (GSK) — a side-by-side from cached financials, not a winner call.
Bank of the James Financial Group (BOTJ) is a banks - regional company listed on NASDAQ.
GlaxoSmithKline PLC ADR (GSK) is a drug manufacturers - general company listed on US.
Latest reported BOTJ revenue for 2026-06-30 was $2.1M. Net income was $6.0M. BOTJ currently screens at market cap $109.5M and trailing P/E 10.0.
GSK does not have a complete income-statement cache yet.
BOTJ currently screens at market cap $109.5M and trailing P/E 10.0. GSK currently screens at market cap $103.31B and trailing P/E 13.5.
Not investment advice. Open the BOTJ and GSK stock pages for the full models.
Not investment advice.